DNAprint Genomics (DNAG)

[Gandolf3]

Question for any/all who attended the SH meeting:

When the quarterly numbers come out in a few days, should we expect bottom line $$ progress to finally give somthing besides lip service to their stated goal of enhancing "shareholder value"

Universities get things published. Publicly traded businesses sell product,make deals and make $$.

What (bottom line) did DNAP do in the last quarter to make shareholders money?

Most of us know about and are not entirely comfortable with the massive dilution going on due to our present funding source. Some choose to see it as a necessary evil, while others see somthing more sinister.

I have chosen to pay attention to other things the last few months. In catching up on DNAP and the boards I see much is the same. Articles published, lots of promise but not much public info and a steadily falling share price from the DNAP side.

I haven't seen much in the way of true information provided by the company( and nothing about the list of questions supposedly emailed to the company well in advance of the meeting) posted about the shareholder meeting. I seems like a non-event.

At what point does this business start producing a share price that heads in a positive direction?

G3